Search Results 241-250 of 23877 for prostate cancer
... cancer treatment to between three and five fractions and prostate cancer treatment to five. That shortens the length of treatments from up to two months to ...
2009 European Randomized Study of Screening for Prostate Cancer and Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial; 2013 American Urological ...
Understanding the Resistance to Enzalutamide in Patients with Castrate Resistant Metastatic Prostate Cancer · Overview · Participation eligibility · Participating ...
Androgens can cause the growth of prostate cancer cells. Androgen-deprivation therapy may lessen the amount of androgens made by the body. It is not yet known ...
Each year about 90,000 men seek treatment for recurrent prostate cancer, and evaluating them for recurrence is a major challenge.
Robotic-assisted prostatectomy has emerged as the leading approach for treating patients with prostate cancer, yet the procedures vary. While a multiport ...
A Study of Prostate Cancer Care and Survivorship Among Sub-Saharan African Immigrant Impacted by Social Determinants of Migrant Health Factors. Print details.
... cancer treatment for lung cancer. Docetaxel injection is also used together with prednisone to treat metastatic castration-resistant prostate cancer (prostate ...
... Prostate Cancer. Rochester, Minn. 99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer ...
... prostate cancer (cancer that has spread) in men. Bicalutamide belongs to the group of medicines called antiandrogens. It works by blocking the effects of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.